MedPath

Investigating the effect of intravenous tranexamic acid in reducing the bleeding volume of acute burn surgical debridement

Phase 3
Recruiting
Conditions
The effect of intravenous tranexamic acid in reducing bleeding volume after surgical debridement of acute burn wounds.
Registration Number
IRCT20240301061135N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients with thermal burns less than 30% of the body surface who are candidates for surgical debridement of acute burn wounds.

Exclusion Criteria

Patients with chemical burns
Patients with history or susceptibility to thrombosis
Patients with a history of sensitivity to tranexamic acid
Patients with subarachnoid hemorrhage
Patients with renal dysfunction
Pregnancy
Breastfeeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The volume of blood lost during surgical debridement of burn wounds. Timepoint: During surgery. Method of measurement: Hemoglobin before and after the operation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath